AMPE (Ampio Pharmaceuticals) Cyclically Adjusted FCF per Share: $-85.49 (As of Dec. 2023)


What is Ampio Pharmaceuticals Cyclically Adjusted FCF per Share?

Ampio Pharmaceuticals AMPE -71.39% Cyclically Adjusted FCF per Share is $-85.49 as of Dec. 2023.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Ampio Pharmaceuticals's adjusted free cash flow per share for the three months ended in Dec. 2023 was $-2.789. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-85.49 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-01), Ampio Pharmaceuticals's current stock price is $0.1831. Ampio Pharmaceuticals's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $-85.49. Ampio Pharmaceuticals's Cyclically Adjusted Price-to-FCF of today is .


Ampio Pharmaceuticals  (OTCPK:AMPE) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Ampio Pharmaceuticals Cyclically Adjusted FCF per Share Related Terms


Ampio Pharmaceuticals Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Ampio Pharmaceuticals's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ampio Pharmaceuticals Cyclically Adjusted FCF per Share Chart

Ampio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -109.21 -107.40 -103.92 -102.24 -85.49

Ampio Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -102.24 -99.87 -95.99 -91.19 -85.49

AMPE vs EFTR, VBIVQ, VRTX: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Ampio Pharmaceuticals's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ampio Pharmaceuticals Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ampio Pharmaceuticals's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Ampio Pharmaceuticals's Cyclically Adjusted Price-to-FCF falls into.



Ampio Pharmaceuticals Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ampio Pharmaceuticals's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-2.789/306.7460*306.7460
=-2.789

Current CPI (Dec. 2023) = 306.7460.

Ampio Pharmaceuticals Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -76.840 236.293 -99.751
201406 -72.780 238.343 -93.667
201409 -50.775 238.031 -65.433
201412 -37.618 234.812 -49.142
201503 -40.746 236.119 -52.934
201506 -31.595 238.638 -40.612
201509 -36.249 237.945 -46.730
201512 -44.902 236.525 -58.233
201603 -28.231 238.132 -36.365
201606 -26.954 241.018 -34.305
201609 -13.955 241.428 -17.731
201612 -13.513 241.432 -17.169
201703 -13.812 243.801 -17.378
201706 -15.277 244.955 -19.131
201709 -13.859 246.819 -17.224
201712 -10.444 246.524 -12.995
201803 -13.743 249.554 -16.893
201806 -10.490 251.989 -12.769
201809 -8.474 252.439 -10.297
201812 -0.434 251.233 -0.530
201903 -6.608 254.202 -7.974
201906 -8.745 256.143 -10.473
201909 -9.996 256.759 -11.942
201912 -9.152 256.974 -10.925
202003 -8.510 258.115 -10.113
202006 -8.270 257.797 -9.840
202009 -4.548 260.280 -5.360
202012 -4.615 260.474 -5.435
202103 -6.320 264.877 -7.319
202106 -3.469 271.696 -3.917
202109 -5.842 274.310 -6.533
202112 -4.959 278.802 -5.456
202203 -6.557 287.504 -6.996
202206 -7.887 296.311 -8.165
202209 -7.882 296.808 -8.146
202212 -5.695 296.797 -5.886
202303 -3.048 301.836 -3.098
202306 -4.502 305.109 -4.526
202309 -0.690 307.789 -0.688
202312 -2.789 306.746 -2.789

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-85.49 mean?
Ampio Pharmaceuticals (AMPE) has a Cyclically Adjusted FCF per Share of $-85.49 as of Dec. 2023. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Ampio Pharmaceuticals and its competitors.
Is Ampio Pharmaceuticals' Cyclically Adjusted FCF per Share too high?
Ampio Pharmaceuticals' current Cyclically Adjusted FCF per Share is $-85.49.
How does Ampio Pharmaceuticals' Cyclically Adjusted FCF per Share compare to EFTR and VBIVQ?
Ampio Pharmaceuticals' Cyclically Adjusted FCF per Share of $-85.49 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Ampio Pharmaceuticals and its competitors. Ampio Pharmaceuticals's current Cyclically Adjusted FCF per Share is $-85.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ampio Pharmaceuticals stock overvalued right now?
Ampio Pharmaceuticals (AMPE) has a current Cyclically Adjusted FCF per Share of $-85.49. The current Cyclically Adjusted FCF per Share is $-85.49. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Ampio Pharmaceuticals (AMPE), the current Cyclically Adjusted FCF per Share is $-85.49 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ampio Pharmaceuticals Business Description

Address 9800 Mount Pyramid Court, Suite 400, Englewood, CO, USA, 80112
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee (OAK) as part of its OA-201 development program (OA-201 program or OA-201).